Paediatric HIV infection - Diagnostic and epidemiological aspects

International Journal of STD and AIDS

Volumn 12, Issue 9, 2001, Pages 549-554

  Yeung, S M ^a   Gibb, D M ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Developing countries; Diagnosis; Epidemiology; HIV; Paediatric

Indexed keywords

AFRICA; ASIA; CHILD; CHILD CARE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOWEST INCOME GROUP; PACIFIC ISLANDS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; VERTICAL TRANSMISSION;

AFRICA SOUTH OF THE SAHARA; ASIA; CHILD; DEVELOPING COUNTRIES; DISEASE TRANSMISSION, VERTICAL; HIV INFECTIONS; HUMANS;

EID: 0034868399     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462011923642     Document Type: Review

References (42)

1. Care of children with HIV infection and AIDS in Africa
2. Care of human immunodeficiency virus-infected children in developing countries
3. Prevention of mother-to-child transmission of HIV in developing countries: Recommendations for practice
4. Mortality after the first year of life among human immunodeficiency virus type 1-infected and uninfected children
5. Morbidity and mortality in European children infected by HIV-1
6. Paediatric AIDS incidence in Europe and the USA, 1985-96
7. Effect of the worldwide epidemic in the United Kingdom: Record linkage in anonymous neonatal seroprevalence surveys
8. Prevention of mother-to-child transmission of HIV-1 infection
9. Breastfeeding by HIV-1 infected women and outcome in their infants: A cohort study from Durban, South Africa
10. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
11. Elective Caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: A randomised clinical trial
12. Risk of human immunodeficiency virus type 1 transmission through breastfeeding
13. Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties
14. Perinatal HIV-1 transmission. Interaction between zidovudine prophylaxis and mode of delivery in the French perinatal cohort
15. Falling HIV vertical transmission and disease progression rates: Estimates from surveillance data in the UK and Eire
16. Prevention of mother-to-child transmission of HIV-1 infection: Alternative strategies and their cost-effectiveness
17. Update: Perinatally acquired HIV/AIDS - United States, 1997
18. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues
19. Cost effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago
20. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: A randomised controlled trial
21. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abdijan, Côte d'Ivoire: A randomised trial
22. 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breast fed children on Côte d'Ivoire and Burkina Faso: A double blind placebo-controlled multicentre trial
23. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
24. The one year safety and efficacy data of the HIVNET 012 trial
25. Selection of nevirapine resistance mutations in Ugandan women and infants receiving NVP prophylaxis to prevent HIV-1 vertical transmission (HIVNET 012)
26. Genotypic resistance analysis in women participating in PACTG 316 with HIV-1 RNA ≥ 10,000 copies/ml
27. Reducing perinatal HIV transmission in developing countries through antenatal and delivery care, and breastfeeding: Supporting infant survival by supporting women's survival
28. Influence of infant-feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa: A prospective cohort study
29. Perinatal intervention trial in Africa: Effect of a birth canal cleansing intervention to prevent HIV transmission
30. The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission
31. Early detection of perinatal human immunodeficiency virus (HIV) type 1 infection using HIV RNA amplification and detection
32. Symptomatic HIV infection in infancy - Clinical and laboratory markers of infection
33. Use of HIV-1 specific immunoglobulin G3 as a serological marker of vertical transmission
34. Predicting human immunodeficiency virus infection by antibody pattern
35. Estimating the rate of mother-to-child transmission of HIV: Report of a workshop on methodological issues
36. Rapid serologic testing with immune-complex-dissociated HIV p24 antigen for early detection of HIV infection in neonates
37. Prospective evaluation of amplification-boosted ELISA for heat-denatured p24 antigen for diagnosis and monitoring of pediatric human immunodeficiency virus type 1 infection
38. Evaluation of a clinical case definition of AIDS in African children
39. Evaluation and simplification of the World Health Organization clinical case definition for paediatric AIDS
40. Persistent or relapsing oral candidiasis as an indicator of HIV disease in children